However, these observations are based on an experimental model for castration-resistant prostate cancer, and the effect of insulin on prostate tumorigenesis during the early phase or in hormone-naïve cancer (such as LNCaP) remains to be elucidated. This evidence concerns the gene INS and prostate carcinoma.